ReviewBiomarker research2020

Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies.

Yuru Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.